411MO Petosemtamab (MCLA-158) monotherapy in previously treated (2L+) recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC): Phase II trial
Authors
C. Tourneau,
J. FayetteC. Even,
Assuntina Sacco,
Amaury Daste,
Irene Braña,
C. Herpen,
Thibault Mazard,
S. Henry,
Michael Saerens,
Andrew Joe,
Eduardo Pennella,
Y-M. Shen,
K. Bol,
Lokesh Jain,
Marta Ferrer,
Richard Leeuw +15 authors
,
Antoine Hollebecque
Tip
Tip